Akita H, Mukai Y, Kubo M, Wada H, et al. Response to letter to the editor: "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer". Surgery 2025 Jan 3:109053. doi: 10.1016/j.surg.2024.109053.
PMID: 39755504